The Mesothelioma Guide Blog

Phase 2 clinical trials are a crucial part of progressing a new medicine or treatment – such as a potentially life-saving therapy for cancer like mesothelioma – to FDA...

An estimated 3,000 people in the United States develop mesothelioma. The rare and aggressive cancer spreads quickly, and treatment often struggles to stop tumors from growing and...

Every approved medical treatment that exists today – whether for cancer, diabetes, rare diseases or infections – started with clinical trials. And that process began with a...

When you or a loved one is facing cancer, every decision – from diagnosis to treatment – can feel overwhelming. Thankfully, modern technology is helping doctors make faster,...

In an about-face following public backlash from the scientific and patient advocacy communities – along with the general public – President Donald Trump and his administration...

In the world of cancer treatment, innovation is everything – and one of the most exciting frontiers today is the emergence of CAR T-cell therapy. While this therapy has made...

When it comes to cancer, not all diagnoses are created equal. While some cancers, like breast or lung cancer, benefit from extensive research, abundant clinical trials, and a...

Update (06/28/2025): The U.S. Attorney’s Office for the Eastern District of Pennsylvania filed criminal charges against the School District of Philadelphia. The filing alleges...

The U.S. Food and Drug Administration (FDA) granted orphan drug status to an oncolytic virus developed for mesothelioma. This special designation allows quicker review of the...

A little more than one year after the U.S. Environmental Protection Agency (EPA) announced a ban of the most popular type of asbestos, the historic decision is being reconsidered...